Johnson & Johnson (JNJ)

TradeGate
Currency in EUR
Disclaimer
148.40
-1.30
(-0.87%)
Closed
Day's Range
148.20
149.90
52 wk Range
137.78
176.76
Volume
5,716
Bid/Ask
148.30 / 148.40
Prev. Close
149.7
Open
149.5
Day's Range
148.2-149.9
52 wk Range
137.78-176.76
Volume
5,716
Average Volume (3m)
9,636
1-Year Change
-12.97%
Shares Outstanding
2,407,969,594
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
179.81
Upside +14.62%

People Also Watch

15.01
T
+0.94%
93.26
MMM
-0.21%
141.58
IBM
-1.11%
203.20
CRM
+0.23%
33.16
GM
+2.50%
How do you feel today about JNJ?
Vote to see community's results!
or

Johnson & Johnson Company Profile

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company’s Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Employees
152700

Income Statement